LOD Before IVF/ICSI in PCOS Patients With High AMH

Sponsor
Mansoura University (Other)
Overall Status
Completed
CT.gov ID
NCT03358199
Collaborator
(none)
120
1
50.9
2.4

Study Details

Study Description

Brief Summary

To evaluate the effect of performing laparoscopic ovarian drilling (LOD) before proceeding to in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) on the cycle outcomes in polycystic ovarian syndrome (PCOS) patients with high antimullerian hormone (AMH) levels

Condition or Disease Intervention/Treatment Phase
  • Procedure: LOD

Detailed Description

Retrospective case-control study of PCOS women with high serum AMH level (≥ 7 ng/ml) who were subjected IVF/ICSI. Women underwent LOD in the preceding 3 months prior to IVF/ICSI (study group) will be compared with a control group of women who did not underwent LOD (control group)

Study Design

Study Type:
Observational
Actual Enrollment :
120 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Official Title:
Laparoscopic Ovarian Drilling Before IVF/ICSI in Polycystic Ovarian Syndrome Patients With High Antimullarian Hormone
Actual Study Start Date :
Mar 22, 2013
Actual Primary Completion Date :
May 31, 2017
Actual Study Completion Date :
Jun 18, 2017

Arms and Interventions

Arm Intervention/Treatment
Study group

PCOS women with AMH level (≥ 7 ng/ml) who underwent LOD in the preceding 3 months prior to IVF/ICSI

Procedure: LOD
Women underwent LOD in the preceding 3 months prior to IVF/ICSI
Other Names:
  • Laparoscopic ovarian drilling
  • Control group

    PCOS women with AMH level (≥ 7 ng/ml) who did not undergo LOD in the preceding 3 months prior to IVF/ICSI

    Outcome Measures

    Primary Outcome Measures

    1. Number of oocytes retrieved [36-38 hours after triggering of oocyte maturation]

      Number of collected oocytes during oocyte retrieval

    2. Oocyte maturity rate [Within one hour after oocyte retrieval]

      Calculated for each woman by dividing the number of mature oocytes (MII oocytes) by the total number of oocytes retrieved

    3. Fertilization rate [20-24 hours after injection (or insemination)]

      Calculated for each couple by dividing the number of fertilized oocytes by the number of injected (or inseminated) oocytes

    Secondary Outcome Measures

    1. Clinical pregnancy rate [6 weeks after embryo transfer]

      Number of clinical pregnancies (defined as presence of at least one intrauterine gestational sac with fetal pole and cardiac activity on TVS scan at 4-6 weeks after the ET) divided by the number of ET procedures

    2. Implantation rate [6 weeks after embryo transfer]

      Number of gestational sacs on TVS scan at 4-6 weeks after ET divided by the number of transferred embryos

    3. Incidence of early OHSS [Within 9 days of final triggering of oocyte maturation]

      Incidence of OHSS within 9 days of final triggering of oocyte maturation

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 35 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • PCOS women subjected to COS through fixed gonadotropin releasing hormone (GnRH) antagonist protocol with final triggering of oocyte maturation by GnRH agonist (GnRHa)

    • Elevated serum AMH level (≥ 7 ng/ml)

    Exclusion Criteria:
    • Age < 18 years or > 35 years

    • Body mass index (BMI) < 19 kg/m2 or > 35 kg/m2

    • Use of cabergoline therapy or coasting to minimize the risk of OHSS

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Fertility Care Unit (FCU) in Mansoura University Hospital Mansourah Dakahlia Egypt 35111

    Sponsors and Collaborators

    • Mansoura University

    Investigators

    • Principal Investigator: Mohamed S Abdelhafez, Dr, Mansoura University
    • Study Director: Alaa Wageh, Dr, Mansoura University
    • Study Director: Waleed El-refaie, Dr, Mansoura University
    • Study Director: Maher Shams, Dr, Mansoura University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Mohamed Sayed Abdelhafez, Principal Investigator, Mansoura University
    ClinicalTrials.gov Identifier:
    NCT03358199
    Other Study ID Numbers:
    • MSA6
    First Posted:
    Nov 30, 2017
    Last Update Posted:
    Dec 2, 2017
    Last Verified:
    Nov 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Mohamed Sayed Abdelhafez, Principal Investigator, Mansoura University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 2, 2017